Gufic Biosciences Ltd (BOM:509079)
₹ 405.65 5.4 (1.35%) Market Cap: 40.68 Bil Enterprise Value: 44.00 Bil PE Ratio: 46.68 PB Ratio: 7.64 GF Score: 93/100

Q3 2024 Gufic Biosciences Ltd Earnings Call Transcript

Feb 16, 2024 / 11:00AM GMT
Release Date Price: ₹329.3 (+2.35%)
Operator

Ladies and gentlemen, good day, so the Q3 FY 24 earnings conference call of Gufic Biosciences Limited. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions. The presentation concludes.

I now hand the conference over to Ms. Ami Shah, the Company Secretary. Thank you and over to you ma'am.

Ami Shah
Gufic Biosciences Ltd - Company Secretary

Thank you, Anitha. Good evening, ladies and gentlemen, and a warm welcome to Gufic Biosciences Limited earnings conference call for the third quarter of FY23, '24. I have with me me today Mr. Pranav Choksi, Chief Executive Officer, and Whole time Director; Mr. Devakinandan Roonghta, our Chief Financial Officer, and Mr. Avik Das from Investor Relations team to give the highlights of the business and financial performance of the company and to take queries if any.

We will begin the call with business highlights and overview provided by Mr.Avik, followed by a financial overview from our CFO following the opening remarks and open the floor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot